Header Logo

Connection

Joan Merrill to Injection Site Reaction

Back to Details
This is a "connection" page, showing publications Joan Merrill has written about Injection Site Reaction.
Joan Merrill
Connection Strength
0.038
Injection Site Reaction
  1. Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis. J Rheumatol. 2018 04; 45(4):456-464.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.